Clinical Trial

Oscillometry in the COPD Exacerbator Phenotype With Triple Inhaled Therapy Study

Study acronym: OCTRIS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 17, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this observational study is to determine the effectiveness of inhaled corticosteroids in patients with chronic obstructive pulmonary disease (COPD) and frequent worsening of their respiratory symptoms by using a device called an oscillometer. This instrument is capable of measuring bronchial obstruction and air trapping in the lungs through vibrations during normal breathing. The main question it seeks to answer is: Could oscillometry be useful in assessing the effectiveness of inhaled corticosteroids in patients with COPD exacerbations, in terms of bronchial obstruction and air trapping in the lungs? Patients who choose to participate will undergo oscillometry testing and complete standard COPD questionnaires during three follow-up visits spread over three months.
Trial Details
NCT Number NCT06931899
Lead Sponsor Hospital Universitari de Bellvitge
Collaborators: Institut d'Investigació Biomèdica de Bellvitge, Chiesi España, S.A.U.
Conditions COPD (Chronic Obstructive Pulmonary Disease)
Enrollment 63 participants
Start Date 2025-04
Primary Completion 2026-04 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-17